Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(43%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_3
1
14%
Ph not_applicable
2
29%
Ph phase_4
4
57%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(4)

Detailed Status

Completed4
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (14.3%)
Phase 44 (57.1%)
N/A2 (28.6%)

Trials by Status

completed457%
active_not_recruiting114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7